1. 8040威尼斯(中国)

      Global
      关于8040威尼斯(中国)

      致力于纳米抗体
      创新药物研发

      关于8040威尼斯(中国)
      科研论文
      截止现在，8040威尼斯(中国)生物研发团队在具有重要影响力的期刊上发表研究论文多篇。
      2024-12-03
      Efficient development of nanobody-based affinity chromatography for AAV8 purification.
      发表于:Protein Expression and Purification
      查看更多内容
      2024-10-30
      Ce-MOF@Au-Based Electrochemical Immunosensor for Apolipoprotein A1 Detection Using Nanobody Technology.
      发表于:ACS Applied Materials & Interfaces
      查看更多内容
      2024-06-11
      A novel inhalable nanobody targeting IL-4Rα for the treatment of asthma.
      发表于:J Allergy Clin Immunol.
      查看更多内容
      2024-06-10
      Nanobody-Based Microfluidic Immunosensor Chip Using Tetraphenylethylene-Derived Covalent Organic Frameworks as Aggregation-Induced Electrochemiluminescence Emitters for the Detection of Thymic Stromal Lymphopoietin.
      发表于:Analytical Chemistry
      查看更多内容
      2024-05-16
      A humanized trivalent Nectin-4-targeting nanobody drug conjugate displays potent antitumor activity in gastric cancer.
      发表于:Journal of Nanobiotechnology.
      查看更多内容
      2024-02-16
      High performance production process development and scale-up of ananti-TSLP nanobody
      发表于:Protein expression and purification, 218, 106441.
      查看更多内容
      总计 24 1234